IP Library › Granted Patent US 8,308,707
Granted Patent B2
US 8,308,707 · App. 13/012,426 · Granted Nov 13, 2012

Method and system for drug delivery to the eye

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,308,707
App. No.
13/012,426
Granted
Nov 13, 2012
Kind
B2
Abstract

Methods and systems are provided for delivering drug to the eye. The method and system may include implanting into the eye a device which comprises two or more discrete reservoirs, each reservoir containing a drug; and directing focused light to the implanted device to open a first one of the reservoirs and thereby permit the drug to diffuse from the first reservoir to the patient's eye.

Claims (18)

1. A method of locally administering a drug to an eye of a patient, the method comprising:

implanting into the eye a device which comprises two or more discrete reservoirs, each reservoir containing a drug and being defined by one or more substrate materials, at least one of the one or more substrate materials being impermeable to the drug and impermeable to water and air; and

directing focused light to the implanted device, at a first time, to open a first one of the reservoirs and thereby permit the drug to diffuse from the first reservoir to the eye.

2. The method of claim 1 , wherein the one or more substrate materials comprises a metal or a glass.

3. The method of claim 1 , wherein the one or more substrate materials comprises a multi-laminate material.

4. The method of claim 1 , wherein the drug contained in each reservoir is in a solid form.

5. The method of claim 1 , further comprising directing focused light to the implanted device, at a second later time, to open a second one of the reservoirs and thereby permit the drug to diffuse from the second reservoir to the eye.

6. The method of claim 1 , wherein the focused light is from an ophthalmic laser.

7. The method of claim 1 , wherein the focused light is directed through the cornea of the eye.

8. The method of claim 1 , wherein the drug comprises an angiogenesis inhibitor.

9. The method of claim 1 , wherein the drug comprises a steroid.

10. The method of claim 1 , wherein the drug is released from the first reservoir into intraocular fluid of the eye.

11. A method of selectively opening an implanted containment reservoir for controlled delivery of a drug to a patient, comprising:

implanting in an eye of the patient a medical device which comprises a substrate in which at least one reservoir is located, the at least one reservoir containing a release system which comprises the drug, the at least one reservoir being defined by one or more substrate materials, at least one of the one or more substrate materials being impermeable to the drug and impermeable to water and air; and then

directing focused light from an ophthalmic laser toward the release system in the at least one reservoir to cause the drug to be released from the device to the eye.

12. The method of claim 11 , wherein the substrate material comprises a metal or a glass.

13. The method of claim 11 , wherein the drug contained in the at least one reservoir is in a solid form.

14. The method of claim 11 , wherein the focused light is directed through the cornea of the eye.

Assignments (1)
CHANGE OF NAME Recorded Jun 28, 2016
From: MICROCHIPS, INC.
To: MICROCHIPS BIOTECH, INC.
Reel/Frame 039027/0671 →